Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00306007
Other study ID # H1179-27236-01A
Secondary ID
Status Completed
Phase Phase 4
First received March 17, 2006
Last updated June 23, 2013
Start date November 2005
Est. completion date August 2007

Study information

Verified date June 2013
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The aim of the study is to evaluate the reliability, validity, and acceptability of the London Measure of Unplanned Pregnancy (LMUP) in a U.S. population of women. The researchers hypothesize that the LMUP will be acceptable to a U.S. population and will be reliable and valid.


Description:

The concept of "unplanned pregnancy" is used frequently in health research and policy. The majority of tools used to assess unplanned pregnancy planning have not been validated. Recently the London Measure of Unplanned Pregnancy (LMUP) has been developed and validated. The LMUP had been found to be valid and reproducible, but has not been studied outside of the United Kingdom. If we are able to validate this measure in a U.S. population, its use in studies will improve the quality of data about family planning in U.S. women.


Recruitment information / eligibility

Status Completed
Enrollment 320
Est. completion date August 2007
Est. primary completion date August 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 45 Years
Eligibility Inclusion Criteria:

- Pregnant women

- Basic literacy in English or Spanish needed to participate.

Exclusion Criteria:

- Literacy level lower than 11 years of age

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States San Francisco General Hospital San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT06324929 - Optimizing a Digital AEP Risk Intervention With Native Women and Communities Aim 1 N/A
Recruiting NCT06223165 - Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot N/A
Completed NCT01881321 - Use of Motivational Interviewing to Increase Contraception Use Among Young Women N/A
Completed NCT00997932 - A Pilot Study of Early Postpartum Intrauterine Contraception Phase 4